Hee-Cheol Kim | Physiology | Best Researcher Award-duplicate-1

Prof. Dr. Hee-Cheol Kim | Neuroscience | Best Researcher Award

Professor at Keimyung University School of Medicine, South Korea.

Dr. Hee-Cheol Kim is a seasoned psychiatrist and researcher with over three decades of academic, clinical, and administrative experience. His extensive body of work focuses on neurodegenerative diseases, mental health, type 2 diabetes, and the application of electroconvulsive therapy (ECT). His contributions include numerous publications in reputable journals, a history of leadership roles, and impactful research collaborations.

Profile

Orcid

 

Education šŸŽ“:

Dr. Hee-Cheol Kim began his medical education at Keimyung University School of Medicine, earning his M.D. in 1988. He pursued advanced research in psychiatry, completing his Ph.D. in 2001 at Kyungpook National University. His postgraduate training included a rotating internship and residency in psychiatry at Keimyung University Dongsan Medical Center, solidifying his expertise in mental health care. Dr. Kim’s commitment to global learning led him to New York University School of Medicine, where he served as a visiting professor at the Aging and Dementia Research Center. His multidisciplinary academic foundation and international exposure underpin his innovative contributions to psychiatry and neuropsychiatric research.

Work Experience šŸ’¼:

Dr. Hee-Cheol Kimā€™s career spans academic, clinical, and administrative roles. Since 1996, he has been affiliated with Keimyung University School of Medicine, rising from lecturer to professor. He held prestigious positions, including Dean of the School of Medicine and Vice President of Keimyung University Dongsan Hospital. His administrative expertise extends to directing medical affairs and mental health centers in South Korea. Dr. Kim also led the Keimyung University Brain Research Institute, driving advancements in neuroscience. Internationally, he served as a visiting professor at NYU, where he contributed to dementia research. His leadership, combined with his dedication to patient care and teaching, has made him a pillar in the psychiatric community.

Awards and HonorsĀ šŸ†

Dr. Hee-Cheol Kim has received numerous accolades for his contributions to psychiatry and medical education. His groundbreaking research in dementia, mental health, and neurodegenerative diseases has earned him recognition within the academic and medical communities. Dr. Kim has been honored by prestigious organizations, including the Korean Neuropsychiatric Association and the Korean Society for Affective Disorders. His leadership in psychiatry education has also been acknowledged through awards for his excellence in teaching and mentorship. As a member of multiple national and international psychiatric organizations, he has been celebrated for his dedication to advancing mental health care and fostering interdisciplinary collaborations in research and clinical practice.

Research Interests:

Dr. Hee-Cheol Kimā€™s research is centered on neuropsychiatry, focusing on dementia, neurodegenerative diseases, and the intersection of mental health with chronic medical conditions like type 2 diabetes. He is a pioneer in using electroconvulsive therapy (ECT) for treatment-resistant psychiatric disorders and neurodevelopmental challenges. His studies explore how conditions such as depression and Alzheimerā€™s influence comorbidities, providing critical insights into geriatric mental health. During his tenure at NYU, he contributed to dementia research, emphasizing early diagnosis and interventions. Dr. Kimā€™s recent work includes investigating the impact of COVID-19 on mental health and the association between chronic diseases and neurodegeneration. His research bridges clinical practice and academia, offering innovative solutions to improve patient outcomes and enhance mental health care.

šŸ“š PublicationsĀ 

  • “Risk of dementia in patients with ageā€related medical conditions: a retrospective cohort study”
    • Authors: Not specified in accessible sources.
    • Published in: Psychogeriatrics
    • Year: 2024
    • DOI: 10.1111/psyg.13222
  • “Impact of COVID-19 on the development of major mental disorders in patients visiting a university hospital: a retrospective observational study”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of Yeungnam Medical Science
    • Year: 2024
    • DOI: 10.12701/jyms.2023.01256
  • “Effectiveness and Tolerability of Combination Pharmacotherapy With Stimulant and Non-Stimulant in Children With Attention Deficit Hyperactivity Disorder”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of the Korean Academy of Child and Adolescent Psychiatry
    • Year: 2024
    • DOI: 10.5765/jkacap.230048
  • “Risk of Neurodegenerative Diseases in Elderly Koreans with an Initial Diagnosis of Type 2 Diabetes: A Nationwide Retrospective Cohort Study”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of Diabetes Research
    • Year: 2023
    • DOI: 10.1155/2023/7887792
  • “The Association Between Cancer and Neurodegenerative Diseases: A Retrospective Cohort Study Using the National Health Insurance Service-National Health Information Database”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of Korean Neuropsychiatric Association
    • Year: 2021
    • DOI: 10.4306/jknpa.2021.60.4.307

ConclusionĀ 

Dr. Hee-Cheol Kim stands out as a compelling candidate for the Best Researcher Award due to his prolific academic record, innovative contributions to psychiatry, and significant influence on mental health practices in Korea and beyond. His career demonstrates a harmonious blend of research, teaching, and leadership, making him an exemplary figure in the field. Strengthening interdisciplinary collaborations and expanding his international footprint would further cement his legacy as a leading researcher.

 

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

MD.,PhD at Ā Medical University of Lublin , Poland

Dr. Ryszard Pluta is a distinguished neurologist and neuroscientist, with a medical degree from the Medical Academy in Lublin (1977) and a Ph.D. from the Polish Academy of Sciences (1983). He has served as a Professor at the Mossakowski Medical Research Institute and held prestigious postdoctoral fellowships at the NIH and NYS Institute for Basic Research. A recognized expert in brain ischemia and Alzheimer’s disease, Dr. Pluta has published extensively, including multiple influential books on the subject. He is a recipient of numerous awards and is an active member of several professional societies. His significant contributions to understanding the links between ischemia and Alzheimer’s have established him as a leading figure in neuropathology.

Profile:

ScopusĀ 

Education šŸŽ“

Ryszard Pluta earned his medical degree from the Medical Academy in Lublin (1971-1977) and attended Humboldt University in Berlin (1975) and the University of Cologne (1976). He completed his Ph.D. at the Polish Academy of Sciences in Warsaw (1983). He became an Associated Professor in 1992 and a full Professor in 2004 at the Mossakowski Medical Research Institute, Polish Academy of Sciences.

Work Experience šŸ’¼

Dr. Pluta has held prestigious positions, including postdoctoral fellowships at the NIH in Bethesda, USA (1986-1988), and the NYS Institute for Basic Research in New York (1988-1989). He has been a Visiting Professor at several renowned institutions, including the Max-Planck Institute for Neurological Research and Charles University in Prague.

Skills šŸ§ 

With extensive expertise in neuropathology and neurochemistry, Dr. Pluta specializes in brain ischemia and Alzheimer’s disease research. His skills encompass project management, collaboration with international research teams, and contributions to clinical studies in the field of neuroscience.

Awards and Honors šŸ†

Dr. Pluta has received numerous accolades, including recognition from the Polish Association of Neuropathologists (1980, 1986) and the Polish Academy of Sciences (1982, 1989, 1992). He was also honored by the International Brain Research Organization (1997) and the Alzheimerā€™s Association in Chicago (1998).

Membership šŸ¤

He is an active member of various professional organizations, including the Polish Association of Neuropathologists and the International Society of Neuropathology. Dr. Pluta is recognized among the World’s Top 2% scientists by Stanford University.

Teaching Experience šŸ“š

Dr. Pluta has contributed to the academic community through teaching positions at various universities, where he has shared his knowledge and expertise in neuropathology and neuroscience with students and researchers.

Research Focus šŸ”¬

His research focuses on brain ischemia, its relationship with Alzheimer’s disease, and associated neuropathological changes. He has made significant contributions, such as the documentation of identical changes in ischemic brains and those affected by Alzheimer’s, and the exploration of potential therapeutic approaches involving Ī²-amyloid peptide.

 

Publications:

  • Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer’s Disease with Survival up to 2 Years
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Trans- and Cis-Phosphorylated Tau Protein: New Pieces of the Puzzle in the Development of Neurofibrillary Tangles in Post-Ischemic Brain Neurodegeneration of the Alzheimerā€™s Disease-like Type
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • A Look at the Etiology of Alzheimer’s Disease based on the Brain Ischemia Model
    • Year: 2024
    • Journal: Current Alzheimer Research
  • Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Ischemia-Reperfusion Programming of Alzheimerā€™s Disease-Related Genesā€”A New Perspective on Brain Neurodegeneration after Cardiac Arrest
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • LRP1 and RAGE Genes Transporting Amyloid and Tau Protein in the Hippocampal CA3 Area in an Ischemic Model of Alzheimerā€™s Disease with 2-Year Survival
    • Year: 2023
    • Journal: Cells
  • The Dual Role of Autophagy in Postischemic Brain Neurodegeneration of Alzheimerā€™s Disease Proteinopathy
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Preservation of Biomarkers Associated with Alzheimerā€™s Disease (Amyloid Peptides 1-38, 1-40, 1-42, Tau Protein, Beclin 1) in the Blood of Neonates after Perinatal Asphyxia
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimerā€™s Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids
    • Year: 2023
    • Journal: Molecules
  • Post-Ischemic Permeability of the Bloodā€“Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimerā€™s Disease-Type Brain Neurodegeneration
    • Year: 2023
    • Journal: International Journal of Molecular Sciences

Dr NISHI PATEL | Neuroscience | Best Researcher Award

Dr NISHI PATEL | Neuroscience | Best Researcher AwardĀ Ā  šŸ†

Research Scholar at Bhagwan Mahavir University, Surat , IndiašŸŽ“

Dr. Nishi Jayesh Patel is a dedicated research scholar at Bhagwan Mahavir University, specializing in the study of Parkinson’s Disease šŸ§ . With over four years of significant contributions in this field, she has become an expert in neurodegenerative disorders, particularly focusing on microbiology and probiotics. Dr. Patel has published research on the relationship between gut microflora and Parkinsonā€™s, exploring innovative treatments such as in-vitro probiotic formulations. She is also a member of the Parkinson’s Foundation, continually striving to advance knowledge and treatment for the disease.

 

Professional ProfileĀ 

  • Google ScholarĀ 

Education šŸŽ“

Dr. Patel holds advanced degrees in microbiology and neurological sciences, fueling her passion for neurodegenerative disease research. Her academic excellence and thorough understanding of Parkinson’s Disease enable her to make meaningful strides in the field.

Work Experience šŸ¢

Apart from her research work, Dr. Patel is a seasoned subject matter expert and has contributed significantly to academic assessment by setting papers for national and international entrance exams. Her work in this area has helped shape the academic landscape and ensure high standards for future medical professionals.

Awards and Honors šŸ†

While specific awards are not mentioned, Dr. Patelā€™sĀ numerous professional contributions, including her membership in the Parkinson’s Foundation, speak to her dedication and excellence in the field of medical research.

Research Focus šŸ”

Dr. Patelā€™s core research focuses on probiotics and their role in neurological disorders. She has identified six bacterial strains that are potential candidates for therapeutic use in Parkinsonā€™s Disease, with promising results in balancing GABA collapse, improving drug bioavailability, and controlling disease progression. These isolates show potential in controlling mood, immunity, and digestion, positively influencing patients’ well-being.

 

 

Publications :Ā 

  • Evaluating Probiotic Properties of Gut Microflora for Gut Modulation as an Adjuvant Therapy for Parkinson’s Disease
    Authors: NJ Patel, M Hajoori
    Journal: Journal of Future Foods
    Year: 2025
    Volume: 5
    Issue: 3
    Pages: 304-316
  • Isolation, Characterisation, and Screening of Gut Bacteria for Essential Probiotic Characteristics
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: European Journal of Biomedical and Pharmaceutical Sciences
    Year: 2023
    Volume: 10
    Issue: 11
    Pages: 176-179
  • Comparative Formulation and Evaluation of Probiotic Products Utilizing Different Bacterial Strains: A Comprehensive Study
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Biological Forum ā€“ An International Journal
    Year: 2023
    Volume: 15
    Issue: 5
    Pages: 1747-1752
  • Psychobiotics: The Next Generation Adjuvant Therapy and Its Revolutionary Contribution in Treatment for Parkinsonā€™s Disease
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Futuristic Trends in Medical Sciences
    Year: 2022
    Book: 21, Part 1
    Pages: 1-15
  • Bioremediation of Surfactants by Bacteria Isolated from Spume Used to Scavenge Surfactants Along with Dyes in Washing Textile Effluents
    Author: DRD Nishi Jayesh Patel
    Journal: JETIR Research Journal
    Year: 2020
    Volume: 7
    Issue: 6
    Pages: 1147-1153